This NDC is on FDA's drug shortage list (posted Jul 18, 2023)
Reported reason: Other
Product Information
LIRAGLUTIDE 2-PAK 18 MG/3 ML is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $33.8176 per ML under NDC 71288056385. Its NADAC has been published 63 times since Jun 11, 2025.
FDA first approved this application on Apr 2, 2025. Its Orange Book therapeutic-equivalence code is AP1.
Strength
6 mg/mL
Manufacturer
Meitheal Pharmaceuticals Inc.NDC
71288056385
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
LIRAGLUTIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218115FDA Approved
4/2/2025
TE Code
AP1
On Market Since
4/2/2025
Pharmacological Classes
Price Statistics
The NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has been published 63 times since Jun 11, 2025, and over the history we have for it it has declined 48.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $33.8176 per ML |
|---|---|
| All-time high | $65.6636 (Sep 10, 2025) |
| All-time low | $33.8176 (Aug 19, 2026) |
| 52-week high | $65.6636 |
| 52-week low | $33.8176 |
| Median price | $54.1562 |
| Average price | $51.5419 |
| Largest weekly change | -11.1% (Apr 22, 2026) |
| Weeks tracked | 63 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LIRAGLUTIDE 2-PAK 18 MG/3 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 2-PAK 18 MG/3 ML, manufactured by Meitheal Pharmaceuticals Inc., is $33.8176 per ML (NDC 71288056385), effective Aug 19, 2026.
How has the price of LIRAGLUTIDE 2-PAK 18 MG/3 ML changed over time?
Over the history we have for it, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has declined 48.3%. It has been tracked across 63 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 2-PAK 18 MG/3 ML?
Since Jun 11, 2025, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has ranged from a low of $33.8176 (Aug 19, 2026) to a high of $65.6636 (Sep 10, 2025), with a median of $54.1562 per ML.
Are there cheaper alternatives to LIRAGLUTIDE 2-PAK 18 MG/3 ML?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $32.0017 per ML — about 5% below LIRAGLUTIDE 2-PAK 18 MG/3 ML.
Who manufactures LIRAGLUTIDE 2-PAK 18 MG/3 ML?
LIRAGLUTIDE 2-PAK 18 MG/3 ML (NDC 71288056385) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.
Is LIRAGLUTIDE 2-PAK 18 MG/3 ML in shortage?
Yes — NDC 71288056385 is currently listed in FDA's drug shortage database (posted Jul 18, 2023). Reported reason: Other.